ICAD Share Price

ICAD

US44934S2068

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 01:30:00 17/07/2025 am IST			5-day change	1st Jan Change
3.870 ^USD	+3.75%		-.--%	-

21/25/21	ICAD, Inc.(NasdaqCM:ICAD) dropped from S&P TMI Index	CI
18/25/18	ICAD, Inc.(NasdaqCM:ICAD) dropped from Russell Microcap Value Benchmark Index	CI

Analysts' recommendations: ICAD

17/25/17	RadNet's iCAD Deal to Expand its Digital Health Services and Geographic Presence, Truist Says	MT
17/25/17	BTIG Research Downgrades iCAD to Neutral From Buy	MT
19/23/19	Lake Street Adjusts Price Target on icad to $5 From $2.50, Maintains Buy Rating	MT
13/23/13	JMP Securities Adjusts iCAD's Price Target to $4 From $7, Keeps Outperform Rating	MT
04/23/04	Oppenheimer Adjusts iCAD Price Target to $4 From $5, Maintains Outperform Rating	MT

More recommendations

iCAD Inc is a United Statesâ€‘based company. The Company develops artificial intelligence solutions designed to support healthcare providers in the detection and diagnosis of cancer. The company focuses on providing clinically proven AI technologies that assist medical professionals in identifying cancer earlier, improving diagnostic accuracy, and enhancing workflow efficiency. Its solutions include platforms for cancer detection, breast density assessment, and risk evaluation, enabling clinicians to analyze medical images and support patient care decisions. The company leverages advanced data, clinical evidence, and AIâ€‘driven technologies to deliver tools that integrate into existing healthcare systems and assist in screening and diagnostic processes across global markets.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Income Statement and Estimates

More financial data

Stock Market
Stocks
ICAD Stock

As early as today, start finding the best investment opportunities!

Market Cap	11Cr 9.24Cr 8.49Cr 7.91Cr 15Cr 1.01TCr 15Cr 102.16Cr 40Cr 493.41Cr 40Cr 39Cr 1.7TCr	P/E 2023	-9.35x	P/E 2024	-8.59x
Enterprise Value	8.87Cr 7.77Cr 7.14Cr 6.65Cr 13Cr 846.51Cr 13Cr 86Cr 33Cr 414.7Cr 33Cr 33Cr 1.43TCr	EV / Sales 2023	1.47x	EV / Sales 2024	1.6x
Free-Float	99.32%	Yield 2023 *	-	Yield 2024	-

08/25/08	ICAD Announces Proxy Advisory Firms ISS and Glass Lewis Recommend Stockholders Vote “FOR” Proposed Acquisition by RadNet, Inc.	AQ
04/25/04	ICAD INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of iCAD, Inc. - ICAD	BU
14/25/14	ICAD Reports Financial Results for First Quarter Ended March 31, 2025	AQ
29/25/29	ICAD Collaborates with Microsoft to provide access to its Mammography Solutions in Microsoft’s Precision Imaging Network (PIN)	AQ
17/25/17	ICAD INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of iCAD, Inc. - ICAD	BU

14/23/14	LA PREMIÈRE ÉTAPE DE L’OPÉRATION CONSISTE EN LA CESSION PAR ICAD…
26/21/26	CAC 40 : Les valeurs à suivre à Paris et en Europe
26/21/26	Les valeurs à suivre à Paris et en Europe (actualisé)
18/19/18	ICAD : annonce l’installation de la solution ProFound AI™ 2D pour la mammographie et pour la tomosynthèse (DBT) 3D au Centre d’Imagerie Paris Nord Sarcelles
25/19/25	Dow Jones Industrial Average : Wall Street attendue en hausse malgré Intel et les doutes sur la croissance

1 year	3.68	3.99
3 years	1.18	4.02
5 years	1.05	17.3
10 years	1.05	21.44

Manager	Title	Age	Since
Dana Brown CEO	Chief Executive Officer	61	10/03/2023
Mark Stolper DFI	Director of Finance/CFO	54	17/07/2025
Dave Katz SEC	Corporate Secretary	-	17/07/2025

ICAD Share Price

Stocks

ICAD

US44934S2068

Advanced Medical Equipment & Technology

Valuation: ICAD

Chart: ICAD

Latest news : ICAD

Analysts' recommendations: ICAD

Press Releases: ICAD

News in other languages: ICAD

Quotes and Performance

Course Extremes

Managers and Directors: ICAD

Latest insider transactions

Other Advanced Medical Equipment & Technology

Financials

Company Profile

Income Statement and Estimates

Date	Insider	Type	Main position	Quantity	% Market Cap.
17/25/17	Dana Brown	Issuer sale	Chief Executive Officer	5,19,350	1.9569%
17/25/17	Eric Lonnqvist	Issuer sale	Chief Financial Officer	1,58,488	0.5972%
17/25/17	Michael Doyle	Issuer sale	Director	87,408	0.3293%

	2023	2024
Net sales	1.73Cr 1.52Cr 1.39Cr 1.3Cr 2.46Cr 165.18Cr 2.5Cr 17Cr 6.49Cr 81Cr 6.5Cr 6.36Cr 279.39Cr	1.96Cr 1.72Cr 1.58Cr 1.47Cr 2.78Cr 187.03Cr 2.83Cr 19Cr 7.35Cr 92Cr 7.36Cr 7.2Cr 316.34Cr
Net income	-48.47L -42.43L -38.98L -36.33L -68.77L -46Cr -70.07L -4.69Cr -1.82Cr -23Cr -1.82Cr -1.78Cr -78Cr	-56.16L -49.16L -45.16L -42.09L -79.68L -54Cr -81.19L -5.43Cr -2.11Cr -26Cr -2.11Cr -2.06Cr -91Cr
Net Debt	-2.12Cr -1.86Cr -1.71Cr -1.59Cr -3.01Cr -202.3Cr -3.07Cr -21Cr -7.95Cr -99Cr -7.96Cr -7.79Cr -342.17Cr	-1.68Cr -1.47Cr -1.35Cr -1.26Cr -2.39Cr -160.66Cr -2.44Cr -16Cr -6.32Cr -79Cr -6.32Cr -6.19Cr -271.75Cr

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ICAD	+3.75%	-.--%	+4.03%	+137.42%	11Cr
THERMO FISHER SCIENTIFIC, INC.	+1.97%	+6.35%	+24.19%	+0.32%	19TCr
INTUITIVE SURGICAL, INC.	+5.87%	+6.02%	-20.81%	+24.59%	14TCr
DANAHER CORPORATION	+2.17%	+4.80%	-1.58%	-17.53%	14TCr
BOSTON SCIENTIFIC CORPORATION	+4.83%	+1.53%	-56.92%	-16.55%	6.4TCr
EDWARDS LIFESCIENCES CORPORATION	+2.59%	+5.25%	+22.27%	+0.04%	5.3TCr
SIEMENS HEALTHINEERS AG	+1.39%	+2.13%	-25.49%	-32.59%	4.38TCr
AGILENT TECHNOLOGIES, INC.	-2.02%	-0.71%	+8.50%	+8.68%	3.77TCr
WATERS CORPORATION	+0.31%	+2.74%	+6.23%	+42.30%	3.71TCr
GE HEALTHCARE TECHNOLOGIES INC.	+1.09%	+1.06%	-13.67%	-19.29%	2.95TCr
Average	+1.23%	+2.13%	-5.32%	+12.74%	7.36TCr
Weighted average by Cap.	+1.25%	+3.37%	-2.72%	+0.03%